四双氨酸 - - 针对癌症治疗的更新专利审查 (2016年至今)
Ankur Kumar Tanwar1, Neha Sengar1, Nobuyuki Mase2
1Departments of Natural Products, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Mohali, India.
Expert opinion on therapeutic patents
|August 10, 2024
概括
四化素 (THIQ) 衍生物显示出作为抗癌剂的前景. 本综述涵盖了2016-2024年THIQ基础的癌症药物专利,突出了它们的治疗潜力.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 癌症仍然是全球主要的死亡原因,由遗传和环境因素驱动.
- 四化素 (THIQ) 是各种已知生物活性的类化合物的核心结构.
- THIQ衍生物是药理学过程和临床研究的组成部分.
研究的目的:
- 审查四化素 (THIQ) 衍生物作为抗癌剂的治疗应用.
- 从2016年到2024年,分析与THIQ基抗癌药物相关的专利.
- 为未来的癌症药物开发确定有前途的THIQ类似物.
主要方法:
- 使用Espacenet,谷歌专利,世界知识产权组织和Sci Finder进行了全面的专利搜索.
- 确定并分析了涵盖THIQ衍生物与抗癌应用的专利.
- 检查了专利中的治疗目标和疗效数据.
主要成果:
- 许多THIQ化合物因其作为抗癌剂的潜力而获得专利.
- 这些THIQ衍生物证明了对各种癌症点的显著疗效.
- 基于THIQ的多目标连接体的开发是重点关注的一个关键领域.
结论:
- THIQ类似物是开发新型抗癌药物的有希望的支架.
- 对基于THIQ的多位配体的进一步研究可能会导致癌症治疗的重大进展.
- 专利格局表明,基于THIQ的瘤药物发现领域的创新仍在继续.
关键词:
1,2,3,4-四 hydroisoquinoline 一,二,三,四 hydroisoquinoline 一,四 hydroisoquinoline 一,四 hydroisoquinoline 一,四 hydroisoquinoline 一,四 hydroisoquinoline 一,四 hydroisoquinoline 一,四 hydroisoquinoline 一,四 hydroisoquinoline 一,四 hydroisoquinoline 一,四 hydroisoquinoline 一,四 hydroisoquinoline 一,四 hydroisoquinoline 一,四 hydroquinoline 一,四 hydroisoquinoline 一,四 hydroquinoline 一,四 hydroisoquinoline 一,四 hydroisoquinoline 一,四 hydroquinoline 一,四 hydroisoquinoline 一,四 hydroquinoline 一,四 hydroquinoline 一,四 hydroquinoline 一,四 hydroisoquinoline 一,四 hydroquinoline 一,四 hydroquinoline在 Bcl-xL 中.癌症 癌症 癌症 癌症在HPK1中,HPK1是在PRMT5中,我们使用了PRMT5.抗癌剂是一种抗癌剂.癌症的目标是癌症.更多相关视频
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.4K
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
3.1K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
